Patent · US Active

Method for treating coronavirus infections

US11779585B2 · kind B2 · utility

0Cited by

19References

18Claims

0Family size

Assignee

OYAGEN, INC. · US

Inventors

Harold C. Smith · Rochester, US
Ryan P. Bennett · Canandaigua, US

Key dates

Filing date	Aug 3, 2022
Grant date	Oct 10, 2023
Priority date	—
Expiry date	Aug 3, 2042

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/4808
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are methods, formulations, and kits for treating coronavirus infections, including Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) infections and SARS-CoV-2 infections. Further disclosed are stop-gap methods for controlling the spread of coronavirus infections and the emergence of drug resistant strains of coronavirus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.